NCT03876210View on ClinicalTrials.gov

Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 12, 2019

Primary Completion Date

July 22, 2019

Study Completion Date

August 5, 2019

Conditions
Arthritis
Interventions
COMBINATION_PRODUCT

PK101

PK101-001 + PK101-002 (combination)

DRUG

PK101-001, PK101-002

coadministration

Trial Locations (1)

Unknown

Clinical Trials Center, Chungnam National University Hospital, Daejeon

All Listed Sponsors
lead

PMG Pharm Co., Ltd

INDUSTRY

NCT03876210 - Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs | Biotech Hunter | Biotech Hunter